StreetAlpha
Cardinal Health Inc · Earnings

CAH Earnings Results and History

Latest: Q1 2027From SEC 8-K, 10-Q and 10-K filingsNext report: Nov 5, 2026

Cardinal Health Inc's earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.

← CAH stock page

Q1 2027 result
Double beat
  • Adjusted EPS$3.26 vs $2.94 est +10.9%
  • GAAP EPS$2.38
  • Revenue$67.51B vs $66.67B est +1.3%
  • Revenue growth+5.5% vs a year ago
  • Outlook RaisedFY2027: $12.80 to $13.00 adjusted EPS

Filed ยท Press release

Revenue growth+18.8%vs −3.8% a year ago
Operating margin1.1%vs 1.0% a year ago
EPS beat rateFree accountlast 9 reports
Avg move afterFree accountnext day, after each report

Key takeaways

from the press release
  • Revenue rose 5% to $67.5 billion, led by 6% growth in Pharmaceutical and Specialty Solutions.
  • Non-GAAP diluted EPS rose 28% to $3.26, helped by higher operating earnings, a lower share count and a lower tax rate.
3 more takeaways with a free account.Create free account

EPS by quarter

GAAP diluted, 12 quarters
Mar 2023: EPS $1.411.41Mar '23Jun 2023: EPS -$0.21-0.21Jun '23Sep 2023: EPS -$0.05-0.05Sep '23Dec 2023: EPS $1.501.50Dec '23Mar 2024: EPS $1.071.07Mar '24Jun 2024: EPS $0.930.93Jun '24Sep 2024: EPS $1.701.70Sep '24Sep 2025: EPS $1.881.88Sep '25

Revenue and operating margin

from 10-Q and 10-K
Mar 2023: revenue $50.5B1%Mar '23Jun 2023: revenue $53.42B0%Jun '23Sep 2023: revenue $54.65B-0%Sep '23Dec 2023: revenue $57.44B1%Dec '23Mar 2024: revenue $54.87B1%Mar '24Jun 2024: revenue $59.87B1%Jun '24Sep 2024: revenue $52.28B1%Sep '24Dec 2024: revenue $55.26B1%Dec '24Mar 2025: revenue $54.88B1%Mar '25Jun 2025: revenue $60.16B1%Jun '25Sep 2025: revenue $64.01B1%Sep '25Dec 2025: revenue $65.63B1%Dec '25
RevenueOperating margin %

Quarter by quarter

from 10-Q and 10-K filings
Quarter endedRevenueGrowthGross marginOp marginNet incomeEPSFree cash flow
Dec 2025$65.63B+18.8%3.7%1.1%$467M–$555M
Sep 2025$64.01B+22.4%3.6%1.0%$450M$1.88$865M
Jun 2025$60.16B+0.5%3.7%0.7%$239M–$1.29B
Mar 2025$54.88B+0.0%3.9%1.3%$506M–$2.79B
Create a free account to see all 12 quarters, or sign in.

EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.

Reports and price reactions

last 9 reports
How CAH moved after each of its last 9 reports, the move options priced in, and StreetAlpha's call. Free account.Create free account

Year by year

fiscal years, from 10-K filings
Year endedRevenueGrowthOp marginNet incomeEPS
Jun 30, 2026$254.2B+14.2%1.0%$1.71B$7.23
Jun 30, 2025$222.6B−1.9%1.0%$1.56B$6.45
Jun 30, 2024$226.8B+10.7%0.5%$852M$3.45
Jun 30, 2023$205B+13.0%0.4%$330M$1.26
Jun 30, 2022$181.3B–−0.3%−$938M−$3.37

Filings and dates

SEC EDGAR
  • Nov 5, 2026Earnings release, Q1 20278-K Press release
  • Nov 5, 2026Next earnings reportexpected
  • Aug 11, 2026Annual report10-K All filings

Also see CAH institutional ownership and the earnings calendar.

CAH earnings FAQ

What were CAH's latest earnings?

For Q1 2027 Cardinal Health Inc reported revenue of $67.51B, GAAP EPS of $2.38 and adjusted EPS of $3.26. The results were filed with the SEC on Nov 5, 2026.

When is CAH's next earnings date?

Cardinal Health Inc is expected to report on Nov 5, 2026. Dates can move until the company confirms them.

Is CAH's revenue growing?

In the quarter ended Dec 31, 2025 revenue was $65.63B, up 18.8% from a year earlier. The table on this page shows every quarter from the company's 10-Q and 10-K filings.

Where do these numbers come from?

Results, guidance and financials come from Cardinal Health Inc's own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.